Advertisement
- This event has passed.
Re-Entering Antibacterial Drug Development
November 16, 2015 - November 18, 2015
The Re-Entering Antibacterial Drug Development Summit is scheduled to take place November 16-18, 2015 in Boston, MA.
This Summit is designed as a forum for knowledge and opinion exchange between the major stakeholders, who are shaping the current state of antibacterial discovery and development.
Conference Overview
Track 1: Antibacterial Research and Development
- Novel Monoclonal Antibodies for the Prevention and Treatment of Bacterial Infections
- Antibiotic Adjuvants to Reclaim Legacy Drugs
- Trench Warfare: The Battle to Push Back the Lines of Gram-Negative Resistance
- New Antibiotics from Natural Products
- and more…
Track 2: Clinical Development and Commercialization of Antibacterials
- Overcoming the Challenges of Developing New Antibiotics for Resistant Bacteria with Regulatory Support and New Diagnostics
- Diagnostics Update: Recent Advances in Pathogen and Antimicrobial Resistance Detection
- Antibacterial Drug Development: The Role of Clinical Microbiology and the Need for Rapid Diagnostics
- The Contribution of Therapeutic Drug Monitoring to Clinical Trial Success and Effective Antibiotic Stewardship
- and more…
Track 3: Diagnostics to Guide Antimicrobial Stewardship and Drug Development
- Rapid DNA-Based Detection of Bacteria at the Point-of-Care Using a Portable Degas-Driven Microfluidic System
- RNA-Based Diagnosis of Antibiotic Resistance
- Luncheon Presentation: Rapid Clonal Diagnostics: Getting Personal with Pathogens at the Point of Care
- We are the World: How Pharmaceutical Industry Can Contribute to Antimicrobial Stewardship
- and more…
Please visit the Re-Entering Antibacterial Drug Development Summit website for more information and registration.